ArticleFrontiers in pharmacology2025

Metabolomic changes associated with treatment response of neoadjuvant chemotherapy with TEC regimen in HER2-negative breast cancer.

Kun Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.